Recruiting

Viral-associated Tumors

Sponsor:

National Cancer Institute (NCI)

Code:

NCT03300830

Conditions

Human Immunodeficiency Virus

Castleman's Disease

Kaposi's Sarcoma

Viral-Associated Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Background:

A person s genome is the collection of all their genes. A gene instructs individual cells to make proteins. Proteins are involved in all of our body s chemical processes. Genome sequencing allows researchers to find variations in genes. Some of these are normal and are not known to cause disease. Some variants are known to cause or affect diseases like cancer. Researchers want to study genetic variants in people with cancer who also have an immunologic disease like HIV.

Objective:

To study the biology of cancer in order to improve ways to prevent, detect, and treat it.

Eligibility:

Adults at least 18 years old with certain cancers and/or immunodeficiencies

Design:

Participants will be screened with medical history, physical exam, and lab tests.

Participants will give samples of one or more tissue type.

They may give blood or urine samples.

Researchers may get samples of tissue when participants have surgery or when the participants are on other protocols in the NCI.

Participants may have a procedure to have tissue samples removed.

Researchers may collect data from participant medical records.

Researchers will compare the genes in a participant s cancer tissue to their normal tissue. They may use the tissue cells to grow new cells in a lab.

Participants may be contacted about the results.

The samples will be stored for future research. No personal data will be kept with them.

...

Conditions

Human Immunodeficiency Virus

Castleman's Disease

Kaposi's Sarcoma

Viral-Associated Cancer

Study ID

NCT03300830

Start date

Dec 20, 2017

Status verified date

Aug 20, 2026

Completion date

Jun 25, 2037

Anticipated

Primary completion date

Jun 7, 2037

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

  • INCLUSION CRITERIA:

Participants with one or more of the following:

  • HIV or other acquired immunodeficiency and cancer
  • Viral-associated cancer or cancer hypothesized to be caused by a virus
  • HIV-negative participants with cancer that commonly occurs in people with HIV

--KSHV-associated malignancy or related diseases, such as Multicentric Castleman Disease (MCD)
  • A malignancy hypothesized to be caused by an endogenous retrovirus
  • Idiopathic Castleman disease

Cancer diagnoses will be confirmed by the NCI Laboratory of Pathology (LP). A biopsy will be collected if sufficient archival tissue is not available.

  • Age >=18 years.
  • ECOG performance status <=2 (Karnofsky >=60%) if biopsy to be performed is solely for the purposes of this protocol. Any ECOG performance status will be allowed if biopsy required for participant care or another NIH protocol that allows lower performance status or if enrollment on this protocol is only for the purposes of studying tissue that has already been collected.
  • Participants must have signed or be willing to sign an IRB-approved informed consent document that permits the use of the tumor and other samples for genomic-based molecular characterization projects. Telephone consent for use of archival tissue or tissue collected on another protocol or standard participant care will be permitted.
  • Co-enrollment on other HAMB, NCI, or NIH protocols is allowed

EXCLUSION CRITERIA:

  • Inability to provide informed consent.
  • Pregnancy: Pregnant women will not be allowed to participate in this study because there is not a potential benefit.

Study Design

Enrollment

280 participants

Anticipated

Interventions and Outcome Measures

Arms

group 1

Viral-assoc. cancer; HIV-neg pts with cancer that occurs in HIV pos; KSHV-assoc. cancer or related diseases e.g. multicentric Castleman disease (MCD); retrovirus-induced cancer; Idiopathic Castleman disease

Primary outcome measure

  • Tissue collection [ Time Frame: Time of collection ]

Central Contacts and Locations

Central contacts

Locations

National Institutes of Health Clinical Center

Recruiting

Bethesda, Maryland, United States, 20892

Contacts

For more information at the NIH Clinical Center contact National Cancer Institute Referral Office

888-624-1937

More Information

Sponsor

National Cancer Institute (NCI)

Last update posted

Sep 8, 2026

Last verified

Aug 20, 2026

Keywords

  • Immunodeficiency
  • Viral-Associated Cancer
  • Kaposi Sarcoma Herpes Virus
  • Idiopathic Castleman Disease
  • Endogenous Retroviruses
  • Natural History

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2026-09-08.